TickerFacts.

Abbott Laboratories (ABT): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$7.39B
Year ended 2025-12-31
$7.38B
Trailing 12 months to 2026-03-31
-1.8%
3-year compound annual growth
+5.3%
5-year compound annual growth
+14.8%
10-year compound annual growth
$8.65B2011-12-31: $7.48B2012-12-31: $7.52B2013-12-31: $2.18B2014-12-31: $2.60B2015-12-31: $1.86B2016-12-31: $2.08B2017-12-31: $4.43B2018-12-31: $4.91B2019-12-31: $4.50B2020-12-31: $5.72B2021-12-31: $8.65B2022-12-31: $7.80B2023-12-31: $5.06B2024-12-31: $6.35B2025-12-31: $7.39B$7.39B
2011-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$7.39B+16.4%2026-02-20, From 2025-01-01
2024-12-31$6.35B+25.5%2026-02-20, From 2024-01-01
2023-12-31$5.06B-35.2%2026-02-20, From 2023-01-01
2022-12-31$7.80B-9.8%2025-02-21, From 2022-01-01
2021-12-31$8.65B+51.1%2024-02-16, From 2021-01-01
2020-12-31$5.72B+27.3%2023-02-17, From 2020-01-01
2019-12-31$4.50B-8.3%2022-02-18, From 2019-01-01
2018-12-31$4.91B+10.6%2021-02-19, From 2018-01-01
2017-12-31$4.43B+113.0%2020-02-21, From 2017-01-01
2016-12-31$2.08B+12.2%2019-02-22, From 2016-01-01
2015-12-31$1.86B-28.6%2018-02-16, From 2015-01-01
2014-12-31$2.60B+19.2%2017-02-17, From 2014-01-01
2013-12-31$2.18B-71.0%2016-02-19, From 2013-01-01
2012-12-31$7.52B+0.5%2015-02-27, From 2012-01-01
2011-12-31$7.48Bn/a2014-02-21, From 2011-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Abbott Laboratories (ABT)2025-12-31$7.39B+16.4%
Bristol Myers Squibb Co (BMY)2025-12-31$12.85B-7.9%
AbbVie Inc. (ABBV)2025-12-31$17.82B-0.1%
Pfizer Inc (PFE)2025-12-31$9.07B-7.7%
Merck & Co., Inc. (MRK)2025-12-31$12.36B-31.7%
Johnson & Johnson (JNJ)2025-12-28$19.70B-0.7%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$1.15B+53.3%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$4.08B+11.3%
Viatris Inc (VTRS)2025-12-31$1.94B-2.0%

Compare ABT, BMY, ABBV, PFE side by side · Screen every company in Pharmaceutical Preparations ↗